Bacterial Infection Of Skin — Patent Landscape
1
Approved drugs
13
Active US patents
61/100
Avg vulnerability
—
Annual revenue covered
Originators in Bacterial Infection Of Skin
Cliff calendar — next 15 years
5
29
2
30
1
31
5
37
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Nuzyra
OMADACYCLINE TOSYLATE
|
Paratek Pharms | 13 | 61 | — | 2029-03-05 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 10124014 | Nuzyra | method of use | 75 | 2029-03-05 |
| 9724358 | Nuzyra | method of use | 75 | 2029-03-05 |
| 10124014 | Nuzyra | method of use | 75 | 2029-03-05 |
| 9724358 | Nuzyra | method of use | 75 | 2029-03-05 |
| 9265740 | Nuzyra | method of use | 68 | 2030-10-24 |
| 10111890 | Nuzyra | method of use | 62 | 2037-08-03 |
| 10383884 | Nuzyra | method of use | 62 | 2037-10-31 |
| 10835542 | Nuzyra | method of use | 62 | 2037-10-31 |
| 10383884 | Nuzyra | method of use | 62 | 2037-10-31 |
| 10835542 | Nuzyra | method of use | 62 | 2037-10-31 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 8383610 | Nuzyra | composition of matter | 10 | 2030-09-23 |
| 9314475 | Nuzyra | formulation | 48 | 2031-03-18 |
| 9265740 | Nuzyra | formulation | 55 | 2029-03-05 |
| 10383884 | Nuzyra | method of use | 62 | 2037-10-31 |
| 10835542 | Nuzyra | method of use | 62 | 2037-10-31 |
| 10835542 | Nuzyra | method of use | 62 | 2037-10-31 |
| 10383884 | Nuzyra | method of use | 62 | 2037-10-31 |
| 10111890 | Nuzyra | method of use | 62 | 2037-08-03 |
| 9265740 | Nuzyra | method of use | 68 | 2030-10-24 |
| 9724358 | Nuzyra | method of use | 75 | 2029-03-05 |
Related
- Bacterial Infection Of Skin — full disease profile
- AI Patent Landscape Report — type "bacterial infection of skin" for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner